Concepedia

Maureen C. Ryan

MC

Statistics

Publications

19

Citations

3K

H-Index

17

Active since

1990

Affiliations

Seagen (United States)(Current)

Fred Hutch Cancer Center

University of Washington

Rush University Medical Center

Maureen C. Ryan is an author at Seagen (United States) specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1990–2023

19

Publications

19

Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes

William G. Carter, Maureen C. Ryan, Pamaia J. Gahr · Cell · 1991 · 761 citations

, , +10

SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey et al. · Blood · 2013 · 381 citations

Targeted Disruption of the <i>LAMA3</i> Gene in Mice Reveals Abnormalities in Survival and Late Stage Differentiation of Epithelial Cells

Maureen C. Ryan, Keesook Lee, Yuko Miyashita et al. · The Journal of Cell Biology · 1999 · 306 citations · Full text

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

Leia M. Smith, Albina Nesterova, Maureen C. Ryan et al. · British Journal of Cancer · 2008 · 285 citations · Full text

Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair.

Maureen C. Ryan, Richard Tizard, Donald R. VanDevanter et al. · Journal of Biological Chemistry · 1994 · 279 citations · Full text

, , +24

1–5 of 19